Patent · US Active

Chlamydia antigens

US8637053B2 · kind B2 · utility

0Cited by

4References

8Claims

0Family size

Assignee

President and Fellows of Harvard College · US

Inventors

Darren E. Higgins · Berkeley, US
Todd Gierahn · Brookline, US

Key dates

Filing date	Dec 3, 2008
Grant date	Jan 28, 2014
Priority date	—
Expiry date	Dec 3, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/53
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Chlamydia antigens (e.g., polypeptides, polypeptide fragments, and fusion proteins) are provided. Also provided are vaccines and pharmaceutical compositions for treating or preventing a bacterial infection, such as Chlamydia, in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.